Financial Data and Key Metrics Changes - Net sales for Q3 were $56.6 million, down 3.3% year-over-year, but ahead of expectations [5][16] - Gross margin was 41%, down 370 basis points from the previous year, impacted by new tariffs and an inventory reserve of $1.2 million [17][18] - GAAP EPS for Q3 was a loss of $0.32 compared to a gain of $0.01 last year, while non-GAAP EPS was $0.12 compared to $0.21 last year [20] Business Line Data and Key Metrics Changes - Outdoor lifestyle category net sales increased 5.4% year-over-year to $35.3 million, driven by BOG and MEAT! Your Maker brands [16][8] - Shooting sports category net sales declined 15%, primarily due to softness in aiming solutions [16][8] - New products represented over 26% of net sales in the quarter, indicating strong innovation [9][10] Market Data and Key Metrics Changes - Domestic net sales decreased 3.4%, while international net sales remained flat compared to Q3 of last year [17] - Traditional channel net sales decreased by 2.1%, and e-commerce net sales decreased by 4.6% [17] Company Strategy and Development Direction - The company is focused on disciplined capital allocation and portfolio management, divesting the UST brand due to its inability to benefit from innovation capabilities [11][12] - The strategy emphasizes investing in high-growth brands and product categories, particularly those that combine innovative hardware with digital capabilities [10][15] - The company aims to maintain a strong operating model and navigate the current environment while building long-term value for shareholders [15] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in maintaining net sales and adjusted EBITDA guidance for fiscal 2026 despite ongoing uncertainties [5] - The company anticipates normalization in inventory levels and consumer demand, particularly in the shooting sports category [33][34] - Management noted that consumer spending remains bifurcated, with affluent consumers continuing to spend while lower-income consumers are more cautious [61] Other Important Information - The company ended the quarter with $10.4 million in cash and no debt, maintaining a strong balance sheet [21][24] - Capital expenditures for Q3 were $1.2 million, with a revised full-year CapEx expectation of $3.5 million to $4 million [24] Q&A Session Summary Question: Can you remind us what was pulled forward in the fourth quarter last year? - Retailers pulled in roughly $10 million in the last two weeks of Q4 [31] Question: What is the current state of retailer inventory levels? - Retailers are under-ordering relative to demand, and normalization is expected [33][34] Question: What is driving the increase in inventories? - The increase is primarily due to tariffs, particularly IEEPA and Section 232 tariffs [40] Question: Will there be continued gross margin pressure in the first half of 2027? - Yes, continued gross margin pressure is expected as capitalized tariffs flow through [46][47] Question: How is consumer spending trending? - There is a bifurcation in consumer spending, with affluent consumers continuing to spend while lower-income consumers are more cautious [61]

Kingsway Financial Services (NYSE:KFS) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Company ParticipantsJT Fitzgerald - CEOJames Carbonara - PartnerKent Hansen - CFOMitch Weiman - Senior Portfolio ManagerOperatorGood day, and welcome to the Kingsway fourth quarter 2025 and full year earnings call. At this time, all participants are on a listen-only mode. A question-and-answer session will follow the formal presentation. Please note this conference is being recorded. With me on the call are JT Fitzgerald ...

Hallador Energy Company (NasdaqCM:HNRG) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Company ParticipantsBrent Bilsland - President and CEOJake Sekelsky - Managing Director and Head of Metals and Mining ResearchMatthew Key - VP of Equity ResearchSean Mansouri - Investor Relations AdvisorTodd Telesz - CFOConference Call ParticipantsJeff Grampp - Managing Director and Senior Research AnalystNick Giles - Senior Research AnalystOperatorGood afternoon, and thank you for attending Hallador Energy's fourth qua ...

Runway Growth Finance (NasdaqGS:RWAY) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Company ParticipantsCasey Alexander - Senior ResearchDavid Spreng - CEOErik Zwick - Managing DirectorGreg Greifeld - Chief Investment OfficerQuinlan Abel - Assistant VP of Investor RelationsTom Raterman - CFO and COOConference Call ParticipantsRick Shane - Managing Director and Equity Research AnalystSean-Paul Adams - Senior Research AnalystOperatorLadies and gentlemen, thank you for standing by, and welcome to the Runway ...

KinderCare Learning Companies (NYSE:KLC) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Company ParticipantsOlivia Kirrer - VP of Investor RelationsTom Wyatt - CEOTony Amandi - CFOConference Call ParticipantsAndrew Steinerman - Managing Director and Senior Equity Research AnalystGeorge Tong - VP and Equity Research AnalystJeffrey Meuler - Senior Research AnalystJosh Chan - Executive Director and Equity Research AnalystRonan Kennedy - Equity Research AnalystRyan Griffin - Equity Research AnalystToni Kaplan ...

Karat Packaging (NasdaqGS:KRT) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Company ParticipantsAlan Yu - CEOJian Guo - CFOJoshua Axel - Investment AdviserKyle Benvenuto - Equity Research AssociateRoger Pondel - Investor RelationsConference Call ParticipantsRyan Merkel - Research AnalystRyan Meyers - Senior Research AnalystOperatorGood afternoon, and welcome to the Karat Packaging fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, plea ...

Financial Data and Key Metrics Changes - In Q4 2025, EverCommerce generated revenue of $151.2 million, representing a 5.2% year-over-year growth [6][20] - Adjusted EBITDA for the quarter was $44.2 million, with a margin of 29.2%, reflecting operational discipline and efficiency improvements [21][22] - Pro forma revenue for the last twelve months was $591.7 million, indicating a 6.4% year-over-year growth [8][20] Business Line Data and Key Metrics Changes - EverPro and EverHealth verticals accounted for approximately 95% of consolidated revenue, with significant investments in AI capabilities [7][11] - Multi-solution customers grew by 26% year-over-year, with 286,000 customers enabled for more than one solution [16] - The top six payment solutions experienced a 17.4% year-over-year growth in total payment volume [17] Market Data and Key Metrics Changes - The annualized total payments volume expanded to $13 billion, showcasing the growth potential in the payments segment [8] - The company reported a net revenue retention rate of 96%, with multi-solution customers generating NRR above 100% [17] Company Strategy and Development Direction - The company is focused on embedding AI across its platforms to enhance customer experiences and operational efficiency [63] - Investments in AI-driven features and workflows are expected to drive durable growth and improve cash flow generation [26][63] - The acquisition of ZyraTalk is seen as a foundational step towards building an agentic platform for enhanced customer engagement [10][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth prospects for 2026, driven by AI investments and improved customer engagement strategies [36][58] - The company anticipates continued operational improvements and a focus on delivering enhanced customer experiences through AI [63] Other Important Information - The company repurchased approximately 2.5 million shares for $24.8 million in Q4 2025, reflecting a commitment to returning value to shareholders [25] - The leadership update included Matt Feierstein taking on the role of CEO for EverPro, emphasizing continuity in strategy execution [18] Q&A Session Summary Question: Customer appetite for AI solutions - Management noted strong uptake in AI functionalities across EverPro, with positive early sales from ZyraTalk integrations [30][31] Question: 2026 growth outlook assumptions - The growth outlook is supported by investments in AI and expectations of re-acceleration in revenue through the year [36][39] Question: Payments revenue decline explanation - The decline in non-top six payment solutions was not significantly related to the MarTech divestiture, with focus on mature and growth segments of the portfolio [42][44] Question: Competitive advantages in the AI landscape - Management highlighted deep niche vertical expertise and a large customer base as key advantages in adapting to AI advancements [45][47] Question: Incremental revenue from no-show prediction tool - The no-show prediction tool is included in packages, with expectations of increased overall ASP as new features are added [51]

Afya (NasdaqGS:AFYA) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Company ParticipantsAndre Salles - DirectorFlavio Yoshida - VP of Equity Research for Latin America FinancialsLucca Marquezini - Equity Research AssociateLuis André Blanco - CFOMauricio Cepeda - Equity Research Executive Director of Healthcare and Education LatamRenata Couto - Director of Investor RelationsVirgilio Gibbon - CEOConference Call ParticipantsMarcelo Santos - Senior Sell-side Equity Analyst covering TMT & EducationRenata Couto ...

Financial Data and Key Metrics Changes - The Oncology Institute achieved a revenue increase of approximately 28% year-over-year, surpassing $500 million for the first time in its history, with total revenue for Q4 2025 reaching $142 million, a 41.6% year-over-year growth [5][20] - Adjusted EBITDA for Q4 2025 was $147,000, improving from a loss of $7.8 million in Q4 2024, marking the first profitable quarter from an adjusted EBITDA perspective as a public company [4][24] - SG&A expenses decreased by 2% year-over-year, reflecting operational efficiency, with SG&A as a percentage of revenue dropping from 24.8% to 19.7% [7][23] Business Line Data and Key Metrics Changes - The fee-for-service business grew 9% year-over-year from $136.2 million to $148.5 million, while the capitation business grew 17.2% year-over-year from $68.7 million to $80.5 million [17] - Pharmacy revenue grew 49.6% year-over-year from $179.9 million to $269.2 million, driven by improved prescription attachment rates [18] Market Data and Key Metrics Changes - The company expanded its capitated care model, initiating 9 new capitated contracts in California, Florida, and Nevada, adding approximately 260,000 patient lives under management [5][8] - The Florida Oncology Network platform grew to approximately 207 participating providers, supporting a hybrid model of patient care [10] Company Strategy and Development Direction - The Oncology Institute aims to continue scaling its value-based care platform, with a focus on expanding payer partnerships and achieving sustainable profitability [11][13] - The company plans to launch a proprietary network portal in Q2 2026 to enhance provider engagement and improve operational efficiencies [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year positive adjusted EBITDA in 2026, driven by strong growth in the delegated capitation model [4][11] - The impact of the Inflation Reduction Act on the company's revenue is expected to be minor, with management indicating multiple strategies to offset any potential negative effects [15][16] Other Important Information - The company reduced debt on its convertible preferred note by $24 million, ending the year with $33.6 million in cash [8] - The leadership team was strengthened with new appointments, enhancing the company's ability to scale and execute its growth strategy [10][12] Q&A Session Summary Question: What drove the higher dispensing revenue in the quarter? - Management attributed the strong performance to operational execution in mitigating prescription leakage and strong patient encounter growth related to capitated contracts [30][31] Question: Will the Elevance contract size double in Florida in 2026? - Yes, that is the goal [32] Question: What is the size of the total addressable market for Elevance or Humana? - There is significant opportunity for growth, with many multiples of current capitated revenue available in Florida [34][35] Question: How are margins looking for capitated revenue? - Performance in terms of volume and medical loss ratio (MLR) is as expected, with no surprises [36] Question: Will SG&A improve in 2026? - Improvements are expected, but not to the same degree as in 2025 due to growth investments [65]

Financial Data and Key Metrics Changes - Net sales for Q4 2025 increased by 13.7% to $115.6 million from $101.6 million in Q4 2024, driven by $8.2 million in volume growth and a $6.3 million favorable impact from pricing and product mix [8][9] - Gross profit for Q4 2025 was $39.3 million, compared to $39.8 million in the prior year quarter, with a gross margin of 34.0%, down from 39.2% [10][11] - Net income for Q4 2025 rose by 22.8% to $7.2 million, with a net income margin of 6.2%, up from 5.8% in the prior year quarter [13] Business Line Data and Key Metrics Changes - Sales to chain accounts and distributors, the largest sales channel, increased by 17.5% in Q4 2025, while online sales rose by 1.9% and retail channel sales declined by 4.8% [9] - The new paper bag business category is gaining momentum, contributing to revenue growth and expanding market share [6][7] Market Data and Key Metrics Changes - Eco-friendly product sales grew to 37.3% of total revenue in Q4 2025, up from 34.5% in Q4 2024, indicating a strong demand for sustainable products [7] Company Strategy and Development Direction - The company is focusing on diversifying sourcing and optimizing margins, with a resilient global supply chain maintaining a gross margin of 34% despite higher tariff costs [5][6] - Continued expansion in the paper bag category and the addition of new customer accounts are key strategies for driving top-line growth [17] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing trade volatility but emphasized the company's ability to deliver profitable growth, expecting net sales to increase by approximately 8%-10% in Q1 2026 and low double-digit growth for the full year [16][17] - The company anticipates improvements in gross margin and adjusted EBITDA margin in 2026 under the current global tariff environment [16] Other Important Information - The company repurchased 137,374 shares at an average price of $21.74 per share, with approximately $12.0 million remaining for repurchase under the authorized program [15] - The company ended 2025 with $91.0 million in working capital and maintained financial liquidity of $45.6 million [15] Q&A Session Summary Question: Outlook for 2026 and market assumptions - Management expects low double-digit growth, primarily driven by market share gains in new product categories, despite a competitive environment [20][21] Question: Q1 revenue slowdown and weather impact - Management confirmed that weather conditions, particularly in Texas, caused a slowdown in Q1, but trends are improving as conditions stabilize [22][23] Question: Full year revenue guidance and business opportunities - Management indicated that the revenue guidance includes potential new accounts in the final confirmation stages, but conservatively accounts for testing phases that may delay revenue recognition [27][28] Question: Margin guidance and energy costs - Management confirmed that energy costs are factored into margin outlook, with expectations of a 10%-15% increase in ocean freight shipping costs year-over-year [38] Question: Online sales growth and future platforms - Management anticipates double-digit growth in online sales for 2026, driven by the addition of new platforms and bulk sales strategies [40][41] Question: Demand for eco-friendly products and California market conditions - Demand for eco-friendly products remains strong, particularly for molded fiber and paper bags, while the California market is experiencing a slowdown due to increased competition [48][49]